1,972
Views
23
CrossRef citations to date
0
Altmetric
Articles

A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma

, , , &
Pages 1207-1214 | Received 14 May 2017, Accepted 07 Aug 2017, Published online: 24 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jia He, Xiaoyun Zhou, Li Li & Zhijun Han. (2020) Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis. Cancer Management and Research 12, pages 289-302.
Read now
Liang Zhang, Shi-Kai Liu, Lili Song & Hai-Rong Yao. (2019) SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 555-563.
Read now
Qian-Kun Sha, Lin Chen, Jia-Zhuang Xi & Hang Song. (2019) Long non-coding RNA LINC00858 promotes cells proliferation, migration and invasion by acting as a ceRNA of miR-22-3p in colorectal cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1057-1066.
Read now

Articles from other publishers (20)

Yishuang Cui, Yanan Wu, Mengshi Zhang, Yingze Zhu, Xin Su, Wenyue Kong, Xuan Zheng & Guogui Sun. (2023) Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data. Frontiers in Oncology 13.
Crossref
Wei Wei, Chao Liu, Meng Wang, Wei Jiang, Caihong Wang & Shuqun Zhang. (2022) Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Frontiers in Genetics 13.
Crossref
Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li & Quqin Lu. (2021) A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma. BMC Cancer 21:1.
Crossref
Nuobei Zhang, Hao Shen, Shenan Huang, Fenfen Wang, Huifang Liu, Fen Xie, Lei Jiang & Xin Chen. (2021) LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma. European Journal of Histochemistry 65:4.
Crossref
Ji Huang, Qiu-Ming He, Qi Wu, Wei-Min Zhou, Chao Hao, Gong-Xian Wang & Xin-Hua Tu. (2021) Long non‑coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR‑3064‑5p/CTGF axis. Oncology Reports 46:2.
Crossref
Zijun Xu, Lijuan Xu, Liping Liu, Hai Li, Jiewen Jin, Miaoguan Peng, Yanrui Huang, Haipeng Xiao, Yanbing Li & Hongyu Guan. (2021) A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Jie Liu, Shiqiang Hou, Jinyi Wang, Zhengjun Chai, Xuan Hong, Tian Zhao, Zhengliang Sun, Liandi Bai, Hongyan Gao, Jing Gao & Guohan Chen. (2020) A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining. Oxidative Medicine and Cellular Longevity 2020, pages 1-11.
Crossref
Guosen Li & Xiangyun Guo. (2020) LncRNA STARD13-AS blocks lung squamous carcinoma cells growth and movement by targeting miR-1248/C3A. Pulmonary Pharmacology & Therapeutics 64, pages 101949.
Crossref
Qi Wan, Jing Tang, Jianqun Lu, Lin Jin, Yaru Su, Shoubi Wang, Yaqi Cheng, Ying Liu, Chaoyang Li & Zhichong Wang. (2020) Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma. Cancer Biomarkers 27:3, pages 343-356.
Crossref
Panpan Lv, Shaoxing Yang, Wenjing Liu, Haifeng Qin, Xiuhua Tang, Fangfang Wu, Zeyuan Liu, Hongjun Gao & Xiaoqing Liu. (2019) Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor‐tyrosine kinase inhibitor therapy . Thoracic Cancer 11:1, pages 29-40.
Crossref
Bin Ma, Yongmin Li & Yupeng Ren. (2019) Identification of a 6‐lncRNA prognostic signature based on microarray re‐annotation in gastric cancer. Cancer Medicine 9:1, pages 335-349.
Crossref
Wen Jiang, Qing Guo, Chenghe Wang & Yu Zhu. (2019) A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell International 19:1.
Crossref
Lizhong Zeng, Wei Wang, Yang Chen, Xin Lv, Jingyan Yuan, Ruiying Sun & Shuanying Yang. (2019) A five‑long non‑coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma. Experimental and Therapeutic Medicine.
Crossref
Nian Liu, Zijian Liu, Xinxin Liu & Hongxiang Chen. (2019) Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma. Frontiers in Oncology 9.
Crossref
Yuting He, Xingsong Li, Yuhuan Meng, Shuying Fu, Ying Cui, Yong Shi & Hongli Du. (2019) A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma. Journal of Cellular Biochemistry 120:10, pages 16692-16702.
Crossref
Lu Xing, Xiaoqian Zhang & Anwei Chen. (2019) Prognostic 4‑lncRNA‑based risk model predicts survival time of patients with head and neck squamous cell carcinoma. Oncology Letters.
Crossref
Pengfei Diao, Yue Song, Han Ge, Yaping Wu, Jin Li, Wei Zhang, Yanling Wang & Jie Cheng. (2018) Identification of 4‐lncRNA prognostic signature in head and neck squamous cell carcinoma. Journal of Cellular Biochemistry 120:6, pages 10010-10020.
Crossref
Wen Yin, Guihua Tang, Quanwei Zhou, Yudong Cao, Haixia Li, Xianyong Fu, Zhaoping Wu & Xingjun Jiang. (2019) Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma. Frontiers in Genetics 10.
Crossref
Zhen Xiang & Yingyan Yu. (2019) Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases. Frontiers of Medicine 13:1, pages 24-31.
Crossref
Yizi Wang, Fang Ren, Peng Chen, Shuang Liu, Zixuan Song & Xiaoxin Ma. (2018) Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma. Cancer Medicine 7:11, pages 5632-5642.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.